M Bátovský

Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial

Wolfgang Kruis, Gediminas Kiudelis, I Rácz et al. · Gut · 2008 · 202 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +14

Budesonide 9 mg Is at Least as Effective as Mesalamine 4.5 g in Patients With Mildly to Moderately Active Crohn's Disease

A Tromm, Ivan Bunganič, Eva Tomsová et al. · Gastroenterology · 2010 · 90 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Randomised clinical trial: a comparative dose-finding study of three arms of dual release mesalazine for maintaining remission in ulcerative colitis

Wolfgang Kruis, Laimas Virginijus Jonaitis, Juris Pokrotnieks et al. · Alimentary Pharmacology & Therapeutics · 2010 · 80 citations

Pharmacy, Pharmacotherapy, Bowel Management +11

Comparison of the efficacy and safety of Eudragit‐L‐coated mesalazine tablets with ethylcellulose‐coated mesalazine tablets in patients with mild to moderately active ulcerative colitis

Peter G. Gibson, B Fixa, B. Pekárková et al. · Alimentary Pharmacology & Therapeutics · 2006 · 49 citations

Medicine, Pharmacology, Pharmacotherapy +13

A double‐blind dose‐escalating trial comparing novel mesalazine pellets with mesalazine tablets in active ulcerative colitis

Y Marakhouski, B Fixa, J Holomáň et al. · Alimentary Pharmacology & Therapeutics · 2005 · 44 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13